fbpx

Hollo

Back

Social Tech, Good Health & Well-Being

Website: http://hollo.hk

Each year, there is an addition of approximately 45 million new chronic disease cases worldwide, and according to WHO’s 2020 study, 91% of these cases would lead to mental health conditions. Mental health conditions not only worsen chronic diseases, but also discourage patients from adhering to medical treatment. Unfortunately, Hong Kong people have considerably inadequate access to mental health resources, considering the psychiatrist-to-population ratio of 4.5:100,000. Determined to make a change, Hollo aims to reduce the inequality of mental healthcare accessibility in an increasingly decentralised healthcare system.

Hollo is an app-based, digital mental healthcare platform for chronic patients, providing them with precision psychiatry treatment through clinically graded Digital Therapeutics (DTx), which is powered by Multimodal Biomarker AI. The Multimodal Biomarker AI allows psychodiagnosis to be done via alternative media (such as using patient videos for facial, vocal, or semantic recognition of any unconscious emotional signals), while also considering the complexity of a patient’s profile, including one’s physical symptoms, mental health reported data, background behavioural data, etc.

Our treatments are digitised and gamified versions of evidence-based interventions, which consist of psychoeducational content, mindfulness activities, and psychological exercises; these would be prescribed to patients as a 5-week programme to work through. By leading them towards mindfulness and value-based goal setting, patients would become more accepting of their life conditions and focus more on the positive aspects of their lives, which would ultimately help them to return to communities and reconnect with others.

We are currently at the stage of validating our products through clinical studies, which are carried out in association with a university research partnership, with the aim to obtain FDA’s approval. For the next step, we hope to partner with insurance companies and pharma to distribute our products via hospitals, clinics, and telemedicine service providers, so that we can help achieve better patient outcomes and higher treatment adherence.

組長
Team Leader
温嘉民
Cameron Xavier VAN BREDA (HKU)

組員
Team Member
莊穎霖
CHONG Wing Lam (HKU)
林敦凱
LIM Tun Hoi Duncan (University College London)
葉永昕
YIH Yong Xin Imogen (Wellesley College)

院校顧問
Faculty Advisor
金婧雯博士
Dr. JIN Jingwen Frances (HKU)

Website
hollo.hk

Contact Us

We welcome your support and participation. Please contact the HKSEC Team.


  • Address

    Room 602, Cheng Yu Tung Building, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

    SHOW MAP

  • Phone

    (852) 3943 9525 / 3943 9628 / 3943 1649


  • Fax

    (852) 2994 4363


  • E-mail

    [email protected]

Leave your contact

Contact Us